UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q/A
Amendment No. 1
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2015
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ______ to ______
Commission file number 1-11353
LABORATORY CORPORATION OF
AMERICA HOLDINGS
(Exact name of registrant as specified in its charter)
| Delaware | 13-3757370 | |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |
| 358 South Main Street, | ||
| Burlington, North Carolina | 27215 | |
| (Address of principal executive offices) | (Zip Code) | |
(Registrant's telephone number, including area code) 336-229-1127
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (paragraph 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer [X] | Accelerated Filer [ ] |
| Non-accelerated filer [ ] (Do not check if a smaller reporting company) | Smaller reporting company [ ] |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [X].
The number of shares outstanding of the issuer's common stock is 101.1 million shares, net of treasury stock as of August 17, 2015.
EXPLANATORY NOTE
The sole purpose of this Amendment No. 1 on Form 10-Q/A to Laboratory Corporation of America Holdings' Form 10-Q for the period ended June 30, 2015 (the “Form 10-Q”), filed with the Securities and Exchange Commission on July 30, 2015 is to provide the conformed signatures of the Chief Executive Officer and Chief Financial Officer which were inadvertently omitted from Exhibit 32. The Company obtained manually-signed copies on July 29, 2015, before filing its Form 10-Q on July 30, 2015.
No other changes have been made to the Form 10-Q other than those described above. This Amendment No. 1 on Form 10-Q/A does not reflect subsequent events occurring after the original filing date of the Form 10-Q or modify or update in any way disclosures made in the Form 10-Q. Among other things, forward-looking statements made in the Form 10-Q have not been revised to reflect events that occurred or facts that became known to the Company after filing of the Form 10-Q, and such forward-looking statements should be read in their historical context. Furthermore, this Form 10-Q/A should be read in conjunction with the Form 10-Q.
Item 6. Exhibits
Number Description
| 32 | Written Statement of Chief Executive Officer and Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following person on behalf of the Registrant and in the capacities on this 20th day of August, 2015.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Registrant
| By: | /s/ GLENN A. EISENBERG | |
| Glenn A. Eisenberg | ||
| Chief Financial Officer | ||
August 20, 2015